scholarly journals COVID‐19 vaccine causing Guillain‐Barre syndrome, a rare potential side effect

2021 ◽  
Vol 9 (9) ◽  
Author(s):  
Ahmad S. Matarneh ◽  
Alia Hani Al‐battah ◽  
Khalid Farooqui ◽  
Mohamed Ghamoodi ◽  
Mohammed Alhatou
Keyword(s):  
Side Effect ◽  
Guillain Barre Syndrome ◽  
Potential Side Effect ◽  
Guillain Barré Syndrome ◽  
Guillain Barré

scholarly journals COVID-19 vaccine causing Guillain barre syndrome, a rare potential side effect

2021 ◽  
Author(s):  
ahmad matarneh ◽  
alia al-battah ◽  
khalid farooqui ◽  
mohamed ghamoodi ◽  
Mohammed alhatou
Keyword(s):  
Side Effect ◽  
Guillain Barre Syndrome ◽  
Variable Degree ◽  
Potential Side Effect ◽  
The World ◽  
Guillain Barré Syndrome ◽  
Guillain Barré

COVID-19 Virus has affected the world in many ways, resulting in several challenges. COVID 19 vaccines were introduced recently, with a variable degree of immunogenicity and safety. We report a 61-year-old man who had GBS a few days after Receiving The vaccine, his condition improved after 5 days of IVIG

scholarly journals Guillain-Barre Syndrome Following Ad26.Cov2.S Covid-19 Vaccine: A Case Report

2021 ◽  
Vol 10 (2) ◽  
pp. 63-64
Author(s):  
Sushmita Khanal ◽  
Sunil Babu Khanal
Keyword(s):  
Case Report ◽  
Side Effect ◽  
Guillain Barre Syndrome ◽  
Guillain Barré Syndrome ◽  
Rare Side Effect ◽  
Guillain Barré

Guillain-Barre Syndrome has been reported as a rare side effect in the recipients of Johnson & Johnson®'s Janssen Ad26.COV2.S COVID-19 vaccine. We report a case of Guillain-Barre Syndrome in a 50 years old female following the administration of the aforementioned vaccine.

Sign in / Sign up

Export Citation Format

Share Document